Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Thermo Fisher Scientific Forms Technology Alliance Partnership with Princeton Scientists

Published: Tuesday, August 14, 2012
Last Updated: Tuesday, August 14, 2012
Bookmark and Share
The collaboration will focus on advancing LC/MS techniques in life science research.

Thermo Fisher Scientific Inc. has entered into a Technology Alliance Partnership agreement with scientists at Princeton University, establishing a formal collaboration to accelerate research in triple quadrupole and high-resolution accurate mass (HRAM) liquid chromatography-mass spectrometry (LCMS) for life science applications.

The agreement, a broad collaboration between Thermo Fisher scientists and Princeton scientists includes: engaging in research, sharing samples and data that could lead to development of better techniques, exchanging ideas and opinions about improving instrument and software performance, ongoing discourse about current technology issues and publishing new methodologies and scientific advances. The groups had previously collaborated informally.

The alliance will focus on three research areas:

Metabolomics, within the laboratory of Joshua Rabinowitz, professor of chemistry at the Lewis Sigler Institute at Princeton.

Proteomics integrated with Molecular Biology and Infectious Diseases, within the laboratory of Ileana Cristea, assistant professor of molecular biology at Princeton.

Mass spectrometry/proteomics method development, with David Perlman at the Princeton Mass Spectrometry and Synthesizing / Sequencing Facility.
“Academic research labs are tremendous sources of innovation, which is why we’re so pleased to collaborate with Princeton scientists to pursue new paths toward a healthier world,” said Iain Mylchreest, vice president, Research and Development, Thermo Fisher.

“Thermo Fisher is a leader in mass spectrometry, and their equipment has been instrumental in many discoveries by Princeton scientists,” said professor Rabinowitz.

Professor Rabinowitz continued, “This agreement formalizes our commitment to interact openly and actively to expedite the development and application of important new technologies.”

“This Technology Alliance Partnership is a welcomed extension of a productive collaboration that my laboratory has had with Thermo Fisher since I joined Princeton,” added professor Cristea.

Professor Cristea continued, “Examples of these collaborative efforts are the optimization of the MALDI LTQ Orbitrap XL, the use of isobaric tags for quantification of protein interactions and the use of the EASY-Spray technology. This partnership will allow us to expand these collaborative efforts and accelerate the integration of developments in mass spectrometry and important biological discoveries.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Scientific at ASMS 2013
Learn how scientists and researchers are transforming science by applying innovative solutions to a wide range of qualitative and quantitative applications.
Monday, May 13, 2013
Thermo Fisher Scientific to Acquire Life Technologies Corporation
The definitive agreement will see Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share or approximately $13.6 billion.
Monday, April 15, 2013
Thermo Fisher Scientific Reports Q3 Revenue and EPS Results
Revenue increased 5% to a record $3.09 billion for the third quarter with adjusted operating income rising 5% to $576 million.
Wednesday, October 24, 2012
Thermo Fisher Scientific Equips the Scottish Metabolomics Facility with Cutting-Edge Technology to Advance the Field of Metabolomics
Thermo Fisher Scientific Inc., today announced it is providing the Scottish Metabolomics Facility (ScotMet) with cutting-edge technology to advance the field of metabolomics.
Thursday, March 18, 2010
Scientific News
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Turning up the Tap on Microbes Leads to Better Protein Patenting
Mining millions of proteins could become faster and easier with a new technique that may also transform the enzyme-catalyst industry, according to University of California, Davis, researchers.
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Circadian Clock Controls Insulin and Blood Sugar in Pancreas
Map of thousands of genes suggests new therapeutic targets for diabetes.
Cellular Stress Process Identified in Cardiovascular Disease
Combining the investigative tools of genetics, transcriptomics, epigenetics and metabolomics, a Duke Medicine research team has identified a new molecular pathway involved in heart attacks and death from heart disease.
Predicting Adverse Drug Reactions with Higher Confidence
A new integrated computational method helps predicting adverse drug reaction—which are often lethal—more reliably than with traditional computing methods.
A New Way to Starve Lung Cancer?
Metabolic alterations in lung cancer may open new avenues for treating the disease.
Evidence of How Incurable Cancer Develops
Researchers in the West Midlands have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder.
Building a Better Liposome
Computational models suggest new design for nanoparticles used in targeted drug delivery.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos